Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...

The Global Systemic Lupus Erythematosus Treatment Market is valued approximately at USD 2.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.64% over the forecast ...

Intravenous belimumab plus SOC vs placebo plus SOC was not linked to an increased risk for infection among patients with SLE.

Incorporating systemic lupus erythematosus disease activity score (SLEDAS) criteria may enhance treat-to-target strategies ...

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown etiology, representing significant diagnostic and therapeutic challenges. The disease is uncommon but not rare, with a ...

However, for the vast majority of lupus flares the initial treatment has to be systemic glucocorticoids. For most manifestations, prednisone at 0.25–0.5 mg/kg body weight (or equivalent) is ...

Autoimmune diseases like lupus rheumatoid arthritis and psoriasis don’t just affect joints or skin they can silently damage ...

Lolo Lekgoane’s life changed when she was diagnosed with systemic lupus erythematosus. The Mahikeng resident faced immense challenges, including giving up her job, losing mobility and enduring ...

You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...

A team studied the differences between monogenic and nonmonogenic lupus nephritis and the predictors of end-stage kidney disease. Monogenic lupus nephritis is distinct from non-monogenic disease with ...

This year, the Lupus Foundation of America (LFA) is pleased to announce two recipients of grants supporting pediatric lupus research. This year's recipients are Nayimisha Balmuri, MD, Assistant ...